Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study

Anastasia Benedyk; Alexander Moldavski; Markus Reichert; Iris Reinhard; Sarah Lohr; Kristina Schwarz; Oksana Berhe; Anna Höflich; Sven Lautenbach; Christoph von der Goltz; Ulrich Ebner-Priemer; Alexander Zipf; Heike Tost; Andreas Meyer-Lindenberg

doi:10.1016/j.euroneuro.2023.01.008

Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study

Anastasia Benedyk, Alexander Moldavski, Markus Reichert, Iris Reinhard, Sarah Lohr, Kristina Schwarz, Oksana Berhe, Anna Höflich, Sven Lautenbach, Christoph von der Goltz, Ulrich Ebner-Priemer, Alexander Zipf, Heike Tost, Andreas Meyer-Lindenberg^*

^*Corresponding author for this work

Division of Psychiatry and Psychotherapeutic Medicine (University Hospital Tulln)

Research output: Journal article (peer-reviewed) › Journal article

1 Citation (Scopus)

Abstract

The COVID-19 pandemic strongly impacted people's daily lives. However, it remains unknown how the pandemic situation affects daily-life experiences of individuals with preexisting severe mental illnesses (SMI). In this real-life longitudinal study, the acute onset of the COVID-19 pandemic in Germany did not cause the already low everyday well-being of patients with schizophrenia (SZ) or major depression (MDD) to decrease further. On the contrary, healthy participants’ well-being, anxiety, social isolation, and mobility worsened, especially in healthy individuals at risk for mental disorder, but remained above the levels seen in patients. Despite being stressful for healthy individuals at risk for mental disorder, the COVID-19 pandemic had little additional influence on daily-life well-being in psychiatric patients with SMI. This highlights the need for preventive action and targeted support of this vulnerable population.

Original language	English
Pages (from-to)	79-83
Number of pages	5
Journal	European Neuropsychopharmacology
Volume	69
DOIs	https://doi.org/10.1016/j.euroneuro.2023.01.008
Publication status	Published - Apr 2023

Keywords

COVID-19
Depression
Mental health risk
Pandemic
Schizophrenia
Vulnerable population

ASJC Scopus subject areas

Pharmacology
Neurology
Neurology (clinical)
Psychiatry and Mental Health
Biological Psychiatry
Pharmacology (medical)

Access to Document

10.1016/j.euroneuro.2023.01.008

Fingerprint

Dive into the research topics of 'Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study'. Together they form a unique fingerprint.

Cite this

Benedyk, A., Moldavski, A., Reichert, M., Reinhard, I., Lohr, S., Schwarz, K., Berhe, O., Höflich, A., Lautenbach, S., von der Goltz, C., Ebner-Priemer, U., Zipf, A., Tost, H., & Meyer-Lindenberg, A. (2023). Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study. European Neuropsychopharmacology, 69, 79-83. https://doi.org/10.1016/j.euroneuro.2023.01.008

@article{70d88a6205d64c7aa8474039a7edef2d,

title = "Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study",

abstract = "The COVID-19 pandemic strongly impacted people's daily lives. However, it remains unknown how the pandemic situation affects daily-life experiences of individuals with preexisting severe mental illnesses (SMI). In this real-life longitudinal study, the acute onset of the COVID-19 pandemic in Germany did not cause the already low everyday well-being of patients with schizophrenia (SZ) or major depression (MDD) to decrease further. On the contrary, healthy participants{\textquoteright} well-being, anxiety, social isolation, and mobility worsened, especially in healthy individuals at risk for mental disorder, but remained above the levels seen in patients. Despite being stressful for healthy individuals at risk for mental disorder, the COVID-19 pandemic had little additional influence on daily-life well-being in psychiatric patients with SMI. This highlights the need for preventive action and targeted support of this vulnerable population.",

keywords = "COVID-19, Depression, Mental health risk, Pandemic, Schizophrenia, Vulnerable population",

author = "Anastasia Benedyk and Alexander Moldavski and Markus Reichert and Iris Reinhard and Sarah Lohr and Kristina Schwarz and Oksana Berhe and Anna H{\"o}flich and Sven Lautenbach and {von der Goltz}, Christoph and Ulrich Ebner-Priemer and Alexander Zipf and Heike Tost and Andreas Meyer-Lindenberg",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2023",

month = apr,

doi = "10.1016/j.euroneuro.2023.01.008",

language = "English",

volume = "69",

pages = "79--83",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

}

Benedyk, A, Moldavski, A, Reichert, M, Reinhard, I, Lohr, S, Schwarz, K, Berhe, O, Höflich, A, Lautenbach, S, von der Goltz, C, Ebner-Priemer, U, Zipf, A, Tost, H & Meyer-Lindenberg, A 2023, 'Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study', European Neuropsychopharmacology, vol. 69, pp. 79-83. https://doi.org/10.1016/j.euroneuro.2023.01.008

Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study. / Benedyk, Anastasia; Moldavski, Alexander; Reichert, Markus et al.
In: European Neuropsychopharmacology, Vol. 69, 04.2023, p. 79-83.

Research output: Journal article (peer-reviewed) › Journal article

TY - JOUR

T1 - Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls

T2 - A longitudinal ecological momentary assessment study

AU - Benedyk, Anastasia

AU - Moldavski, Alexander

AU - Reichert, Markus

AU - Reinhard, Iris

AU - Lohr, Sarah

AU - Schwarz, Kristina

AU - Berhe, Oksana

AU - Höflich, Anna

AU - Lautenbach, Sven

AU - von der Goltz, Christoph

AU - Ebner-Priemer, Ulrich

AU - Zipf, Alexander

AU - Tost, Heike

AU - Meyer-Lindenberg, Andreas

PY - 2023/4

Y1 - 2023/4

N2 - The COVID-19 pandemic strongly impacted people's daily lives. However, it remains unknown how the pandemic situation affects daily-life experiences of individuals with preexisting severe mental illnesses (SMI). In this real-life longitudinal study, the acute onset of the COVID-19 pandemic in Germany did not cause the already low everyday well-being of patients with schizophrenia (SZ) or major depression (MDD) to decrease further. On the contrary, healthy participants’ well-being, anxiety, social isolation, and mobility worsened, especially in healthy individuals at risk for mental disorder, but remained above the levels seen in patients. Despite being stressful for healthy individuals at risk for mental disorder, the COVID-19 pandemic had little additional influence on daily-life well-being in psychiatric patients with SMI. This highlights the need for preventive action and targeted support of this vulnerable population.

AB - The COVID-19 pandemic strongly impacted people's daily lives. However, it remains unknown how the pandemic situation affects daily-life experiences of individuals with preexisting severe mental illnesses (SMI). In this real-life longitudinal study, the acute onset of the COVID-19 pandemic in Germany did not cause the already low everyday well-being of patients with schizophrenia (SZ) or major depression (MDD) to decrease further. On the contrary, healthy participants’ well-being, anxiety, social isolation, and mobility worsened, especially in healthy individuals at risk for mental disorder, but remained above the levels seen in patients. Despite being stressful for healthy individuals at risk for mental disorder, the COVID-19 pandemic had little additional influence on daily-life well-being in psychiatric patients with SMI. This highlights the need for preventive action and targeted support of this vulnerable population.

KW - COVID-19

KW - Depression

KW - Mental health risk

KW - Pandemic

KW - Schizophrenia

KW - Vulnerable population

UR - http://www.scopus.com/inward/record.url?scp=85147957300&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2023.01.008

DO - 10.1016/j.euroneuro.2023.01.008

M3 - Journal article

C2 - 36791492

AN - SCOPUS:85147957300

SN - 0924-977X

VL - 69

SP - 79

EP - 83

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -

Benedyk A, Moldavski A, Reichert M, Reinhard I, Lohr S, Schwarz K et al. Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study. European Neuropsychopharmacology. 2023 Apr;69:79-83. doi: 10.1016/j.euroneuro.2023.01.008

Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this